Why Does Your CRO’s Assignment Practice for CRAs Matter?
Monitoring the progress of the research represents a fundamental aspect of successful outcomes by ensuring that constraints to success are…
Does Your Monitoring Vendor Hold the Key to Improving the Quality of Your Database?
This article will discuss how involving your specialized CRO early in the database development phase can reduce the risk of…
Will Canada’s Multi-Center Approval Processes Help Your Oncology Clinical Trial Exceed Pivotal Milestones?
For the Sponsor choosing Canada to help meet and exceed pivotal corporate objectives on their oncology trial, First Site Opened…
Exploring a ‘Rescue’ Strategy for Your Oncology Clinical Trial?
Although not formally defined within the industry, the term ‘rescue’ is commonly linked with clinical trials where enrollment is falling…
Effectively Integrating a Regionally Specialized CRO Team into Your Existing US/Global Study Framework
The expansion of an oncology study to ex-US areas, such as Canada, brings many advantages, including faster patient accrual and…
Key Attributes of First-In-Class Oncology Clinical Trial Sponsors
Key Attributes of First-In-Class Oncology Clinical Trial Sponsors Overcoming Current Industry Challenges through Excellence Current industry trends that increasingly contribute…
Navigating Canadian Regulations for Oncology Clinical Research – Part II
Navigating Canadian Regulations for Oncology Clinical Research Your Questions Answered Part II Senior executives from oncology drug developers looking to…
20 Years of Unparalleled Canadian Oncology Clinical Research Experience
Scimega Research, Canada’s premier oncology contract research organization (CRO), was founded twenty years ago by two dynamic entrepreneurs, Denise Deakin…
Navigating Canadian Regulations for Oncology Clinical Research – Part I
Navigating Canadian Regulations for Oncology Clinical Research Your Questions Answered Part I Senior executives from oncology drug developers looking to…
The Nearshoring Opportunity: Building a Solid Case for Oncology Studies in Canada
US Sponsors of oncology clinical trials often consider expanding their programs to Europe and Asia rather than to the nearby…